{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:36:13Z","timestamp":1786451773711,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41417-026-01050-7","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:35:15Z","timestamp":1781688915000},"page":"847-860","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NCBP1 promotes the malignant progression of Wilms\u2019 tumor through stabilization of KPNA2 mRNA"],"prefix":"10.1038","volume":"33","author":[{"given":"Yintao","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6031-7742","authenticated-orcid":false,"given":"Hang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"1050_CR1","doi-asserted-by":"publisher","first-page":"2333794x2211126","DOI":"10.1177\/2333794X221112637","volume":"9","author":"A Cherraqi","year":"2022","unstructured":"Cherraqi A, El Haddad S, Iraqi Houssaini Z, El Mohtarim R, Lamalmi N, Elkababr M, et al. Nephroblastoma of the big child, a rare entity: about a case. Glob Pediatr Health. 2022;9:2333794x221112637.","journal-title":"Glob Pediatr Health"},{"key":"1050_CR2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.6004\/jnccn.2021.0037","volume":"19","author":"F Balis","year":"2021","unstructured":"Balis F, Green DM, Anderson C, Cook S, Dhillon J, Gow K, et al. Wilms tumor (nephroblastoma), sion 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19:945\u2013977.","journal-title":"J Natl Compr Canc Netw"},{"key":"1050_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jpurol.2023.04.016","volume":"19","author":"J Van Der Jeugt","year":"2023","unstructured":"Van Der Jeugt J, Jamaer C, Berquin C, Decaestecker K, Hoebeke P, Van Laecke E, et al. Robot-assisted radical nephrectomy for Wilms\u2019 tumor in children. J Pediatr Urol. 2023;19:489\u201390.","journal-title":"J Pediatr Urol"},{"key":"1050_CR4","doi-asserted-by":"publisher","first-page":"540","DOI":"10.6004\/jnccn.2022.7099","volume":"20","author":"CJ Long","year":"2022","unstructured":"Long CJ, Mittal S, Kolon TF. Expanding the use of nephron-sparing surgery for Wilms tumor. J Natl Compr Canc Netw. 2022;20:540\u20136.","journal-title":"J Natl Compr Canc Netw"},{"key":"1050_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102133","volume":"6","author":"PDB Tiburcio","year":"2025","unstructured":"Tiburcio PDB, Chen K, Xu L, Chen KS. Suppressing proteasome activity enhances sensitivity to actinomycin D in diffuse anaplastic Wilms tumor. Cell Rep Med. 2025;6:102133.","journal-title":"Cell Rep Med"},{"key":"1050_CR6","doi-asserted-by":"publisher","first-page":"978","DOI":"10.6004\/jnccn.2021.7070","volume":"19","author":"JS Dome","year":"2021","unstructured":"Dome JS, Mullen EA, Dix DB, Gratias EJ, Ehrlich PF, Daw NC, et al. Impact of the first generation of children\u2019s oncology group clinical trials on clinical practice for Wilms tumor. J Natl Compr Canc Netw. 2021;19:978\u201385.","journal-title":"J Natl Compr Canc Netw"},{"key":"1050_CR7","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.21037\/tcr-20-3302","volume":"10","author":"B Hong","year":"2021","unstructured":"Hong B, Dong R. Research advances in the targeted therapy and immunotherapy of Wilms tumor: a narrative review. Transl Cancer Res. 2021;10:1559\u201367.","journal-title":"Transl Cancer Res"},{"key":"1050_CR8","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/14737140.2024.2381537","volume":"24","author":"S Al-Jilaihawi","year":"2024","unstructured":"Al-Jilaihawi S, Spreafico F, Mavinkurve-Groothuis A, Drost J, Perotti D, Koenig C, et al. Bevacizumab-containing treatment for relapsed or refractory Wilms tumor. Expert Rev Anticancer Ther. 2024;24:837\u201343.","journal-title":"Expert Rev Anticancer Ther"},{"key":"1050_CR9","first-page":"774","volume":"3","author":"DF Coutinho","year":"2022","unstructured":"Coutinho DF, Mundi PS, Marks LJ, Burke C, Ortiz MV, Diolaiti D, et al. Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors. Medicines. 2022;3:774\u2013.e777.","journal-title":"Medicines"},{"key":"1050_CR10","doi-asserted-by":"publisher","first-page":"a004820","DOI":"10.1101\/mcs.a004820","volume":"6","author":"P Obasaju","year":"2020","unstructured":"Obasaju P, Shahab S, Dunn E, Rhee DS, Jiang L, Dome JS, et al. BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF\/MEK inhibition. Cold Spring Harb Mol Case Stud. 2020;6:a004820.","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"1050_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/wrna.52","volume":"2","author":"I Topisirovic","year":"2011","unstructured":"Topisirovic I, Svitkin YV, Sonenberg N, Shatkin AJ. Cap and cap-binding proteins in the control of gene expression. Wiley Interdiscip Rev RNA. 2011;2:277\u201398.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"1050_CR12","doi-asserted-by":"publisher","first-page":"e00540","DOI":"10.1128\/MCB.00540-18","volume":"39","author":"R Sen","year":"2019","unstructured":"Sen R, Barman P, Kaja A, Ferdoush J, Lahudkar S, Roy A, et al. Distinct functions of the cap-binding complex in stimulation of nuclear mRNA export. Mol Cell Biol. 2019;39:e00540\u201300518.","journal-title":"Mol Cell Biol"},{"key":"1050_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9192","volume":"6","author":"A Gebhardt","year":"2015","unstructured":"Gebhardt A, Habjan M, Benda C, Meiler A, Haas DA, Hein MY, et al. mRNA export through an additional cap-binding complex consisting of NCBP1 and NCBP3. Nat Commun. 2015;6:8192.","journal-title":"Nat Commun"},{"key":"1050_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18067","volume":"28","author":"J Li","year":"2024","unstructured":"Li J, Zheng L, Song L, Dong Z, Bai W, Qi L. Identification and validation of N(7)-methylguanosine-associated gene NCBP1 as prognostic and immune- associated biomarkers in breast cancer patients. J Cell Mol Med. 2024;28:e18067.","journal-title":"J Cell Mol Med"},{"key":"1050_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35777-2","volume":"13","author":"S Meng","year":"2023","unstructured":"Meng S, Xia Y, Li M, Wu Y, Wang D, Zhou Y, et al. NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc. Sci Rep. 2023;13:8606.","journal-title":"Sci Rep"},{"key":"1050_CR16","doi-asserted-by":"publisher","first-page":"6965","DOI":"10.1111\/jcmm.14581","volume":"23","author":"H Zhang","year":"2019","unstructured":"Zhang H, Wang A, Tan Y, Wang S, Ma Q, Chen X, et al. NCBP1 promotes the development of lung adenocarcinoma through up-regulation of CUL4B. J Cell Mol Med. 2019;23:6965\u201377.","journal-title":"J Cell Mol Med"},{"key":"1050_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2024.06.004","volume":"273","author":"Y Li","year":"2024","unstructured":"Li Y, Luo C, Cai Y, Wu Y, Shu T, Wei J, et al. IGF2BP3\/NCBP1 complex inhibits renal tubular senescence through regulation of CDK6 mRNA stability. Transl Res. 2024;273:1\u201315.","journal-title":"Transl Res"},{"key":"1050_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117140","volume":"241","author":"Y Han","year":"2020","unstructured":"Han Y, Wang X. The emerging roles of KPNA2 in cancer. Life Sci. 2020;241:117140.","journal-title":"Life Sci"},{"key":"1050_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep21410","volume":"6","author":"K Yamada","year":"2016","unstructured":"Yamada K, Miyamoto Y, Tsujii A, Moriyama T, Ikuno Y, Shiromizu T, et al. Cell surface localization of importin \u03b11\/KPNA2 affects cancer cell proliferation by regulating FGF1 signalling. Sci Rep. 2016;6:21410.","journal-title":"Sci Rep"},{"key":"1050_CR20","doi-asserted-by":"publisher","first-page":"13769","DOI":"10.1074\/jbc.M109.095760","volume":"285","author":"K Lott","year":"2010","unstructured":"Lott K, Bhardwaj A, Mitrousis G, Pante N, Cingolani G. The importin beta binding domain modulates the avidity of importin beta for the nuclear pore complex. J Biol Chem. 2010;285:13769\u201380.","journal-title":"J Biol Chem"},{"key":"1050_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/jb\/mvw032","volume":"160","author":"N Yasuhara","year":"2016","unstructured":"Yasuhara N, Kumar PK. Aptamers that bind specifically to human KPNA2 (importin-\u03b11) and efficiently interfere with nuclear transport. J Biochem. 2016;160:259\u201368.","journal-title":"J Biochem"},{"key":"1050_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.clbc.2024.09.006","volume":"25","author":"H Wang","year":"2025","unstructured":"Wang H, Cao Y, Zhang L, Zhao Q, Li S, Li D. RBM15 drives breast cancer cell progression and immune escape via m6A-dependent stabilization of KPNA2 mRNA. Clin Breast Cancer. 2025;25:96\u2013107.","journal-title":"Clin Breast Cancer"},{"key":"1050_CR23","first-page":"4361","volume":"12","author":"J Xia","year":"2022","unstructured":"Xia J, Wu C, Tang Y, Tang J, Zhu D, Zhang F, et al. CircMYH9 increases KPNA2 mRNA stability to promote hepatocellular carcinoma progression in an EIF4A3-dependent manner. Am J Cancer Res. 2022;12:4361\u201372.","journal-title":"Am J Cancer Res"},{"key":"1050_CR24","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41388-018-0590-8","volume":"38","author":"A Ma","year":"2019","unstructured":"Ma A, Tang M, Zhang L, Wang B, Yang Z, Liu Y, et al. USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis. Oncogene. 2019;38:2405\u201319.","journal-title":"Oncogene"},{"key":"1050_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2017-03-735654","volume":"130","author":"MA Jensen","year":"2017","unstructured":"Jensen MA, Ferretti V, Grossman RL, Staudt LM. The NCI Genomic Data Commons as an engine for precision medicine. Blood. 2017;130:453\u20139.","journal-title":"Blood"},{"key":"1050_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/ijms17040475","volume":"17","author":"N Ludwig","year":"2016","unstructured":"Ludwig N, Werner TV, Backes C, Trampert P, Gessler M, Keller A, et al. Combining miRNA and mRNA expression profiles in Wilms tumor subtypes. Int J Mol Sci. 2016;17:475.","journal-title":"Int J Mol Sci"},{"key":"1050_CR27","doi-asserted-by":"publisher","first-page":"11127","DOI":"10.18632\/oncotarget.7152","volume":"7","author":"J Karlsson","year":"2016","unstructured":"Karlsson J, Valind A, Jansson C, O\u2019Sullivan MJ, Holmquist Mengelbier L, Gisselsson D. Aberrant epigenetic regulation in clear cell sarcoma of the kidney featuring distinct DNA hypermethylation and EZH2 overexpression. Oncotarget. 2016;7:11127\u201336.","journal-title":"Oncotarget"},{"key":"1050_CR28","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s11427-023-2495-x","volume":"67","author":"Z Hu","year":"2024","unstructured":"Hu Z, Li M, Chen Y, Chen L, Han Y, Chen C, et al. Disruption of PABPN1 phase separation by SNRPD2 drives colorectal cancer cell proliferation and migration through promoting alternative polyadenylation of CTNNBIP1. Sci China Life Sci. 2024;67:1212\u201325.","journal-title":"Sci China Life Sci"},{"key":"1050_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.7150\/jca.65225","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Xu F, Lu L, Yang F, Huang X, Lv L, et al. The diagnostic and prognostic significance of small nuclear ribonucleoprotein Sm D1 aberrantly high expression in hepatocellular carcinoma. J Cancer. 2022;13:184\u2013201.","journal-title":"J Cancer"},{"key":"1050_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2423349122","volume":"122","author":"K Chauhan","year":"2025","unstructured":"Chauhan K, Datta D, Kapoor Y, Passricha N, Dutt R, Arora N, et al. A Mycobacterium tuberculosis secreted virulence factor Rv1435c\/hsr1 disrupts host snRNP biogenesis. Proc Natl Acad Sci USA. 2025;122:e2423349122.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1050_CR31","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19050","volume":"13","author":"S Li","year":"2025","unstructured":"Li S, Wang Y, Yang X, Li M, Li G, Song Q, et al. NCBP2 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis. PeerJ. 2025;13:e19050.","journal-title":"PeerJ"},{"key":"1050_CR32","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1515\/med-2021-0257","volume":"16","author":"C Xu","year":"2021","unstructured":"Xu C, Liu M. Integrative bioinformatics analysis of KPNA2 in six major human cancers. Open Med (Wars). 2021;16:498\u2013511.","journal-title":"Open Med (Wars)"},{"key":"1050_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30856","volume":"71","author":"G Fichera","year":"2024","unstructured":"Fichera G, Bisogno G, Affinita MC, Causin F, Giraudo C, Tagarelli A. Lung relapse pattern in children with metastatic Wilms tumor. Pediatr Blood Cancer. 2024;71:e30856.","journal-title":"Pediatr Blood Cancer"},{"key":"1050_CR34","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.3390\/cancers13133142","volume":"13","author":"A Groenendijk","year":"2021","unstructured":"Groenendijk A, Spreafico F, de Krijger RR, Drost J, Brok J, Perotti D, et al. Prognostic factors for Wilms tumor recurrence: a review of the literature. Cancers. 2021;13:3142.","journal-title":"Cancers"},{"key":"1050_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30342","volume":"70","author":"MV Ortiz","year":"2023","unstructured":"Ortiz MV, Koenig C, Armstrong AE, Brok J, de Camargo B, Mavinkurve- GroothuisAMC, et al. Advances in the clinical management of high-risk Wilms tumors. Pediatr Blood Cancer. 2023;70:e30342.","journal-title":"Pediatr Blood Cancer"},{"key":"1050_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10585-012-9457-5","volume":"29","author":"D Spano","year":"2012","unstructured":"Spano D, Zollo M. Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis. 2012;29:381\u201395.","journal-title":"Clin Exp Metastasis"},{"key":"1050_CR37","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1200\/JCO.2011.35.8747","volume":"30","author":"A Verschuur","year":"2012","unstructured":"Verschuur A, Van Tinteren H, Graf N, Bergeron C, Sandstedt B, de Kraker J. Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy. J Clin Oncol. 2012;30:3533\u20139.","journal-title":"J Clin Oncol"},{"key":"1050_CR38","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.jpedsurg.2021.12.037","volume":"57","author":"R Sadeghi","year":"2022","unstructured":"Sadeghi R, Shojaeian R, Hiradfar M, Mohammadipour A, Azadmand A, Mashhadi MP. Sentinel lymph node biopsy in pediatric Wilms tumor. J Pediatr Surg. 2022;57:1518\u201322.","journal-title":"J Pediatr Surg"},{"key":"1050_CR39","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/SLA.0b013e3181b76f20","volume":"250","author":"PF Ehrlich","year":"2009","unstructured":"Ehrlich PF, Ferrer FA, Ritchey ML, Anderson JR, Green DM, Grundy PE, et al. Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the Children\u2019s Oncology Group\/National Wilms Tumor Study Group. Ann Surg. 2009;250:642\u201348.","journal-title":"Ann Surg"},{"key":"1050_CR40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13046-018-0861-9","volume":"37","author":"J Li","year":"2018","unstructured":"Li J, Liu Q, Liu Z, Xia Q, Zhang Z, Zhang R, et al. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc. J Exp Clin Cancer Res. 2018;37:194.","journal-title":"J Exp Clin Cancer Res"},{"key":"1050_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6694392","volume":"2021","author":"KX Zhou","year":"2021","unstructured":"Zhou KX, Huang S, Hu LP, Zhang XL, Qin WT, Zhang YL, et al. Increased nuclear transporter KPNA2 contributes to tumor immune evasion by enhancing PD-L1 expression in PDAC. J Immunol Res. 2021;2021:6694392.","journal-title":"J Immunol Res"},{"key":"1050_CR42","doi-asserted-by":"publisher","first-page":"9255","DOI":"10.1111\/jcmm.16846","volume":"25","author":"S Zheng","year":"2021","unstructured":"Zheng S, Li X, Deng T, Liu R, Bai J, Zuo T, et al. KPNA2 promotes renal cell carcinoma proliferation and metastasis via NPM. J Cell Mol Med. 2021;25:9255\u201367.","journal-title":"J Cell Mol Med"},{"key":"1050_CR43","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3892\/ol.2024.14579","volume":"28","author":"X Chen","year":"2024","unstructured":"Chen X, Bao Y, Sun G, Wang X, Zhu J. UNC13B regulates the sensitivity of Wilms\u2019 tumor cells to doxorubicin by modulating lysosomes. Oncol Lett. 2024;28:446.","journal-title":"Oncol Lett"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01050-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:49:42Z","timestamp":1786448982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01050-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01050-7","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare is no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}